Results 31 to 40 of about 569,058 (302)

Study protocol for a cluster-randomized controlled trial of an NCD access to medicines initative: Evaluation of Novartis Access in Kenya [PDF]

, 2016
INTRODUCTION: Novartis recently launched Novartis Access, an initiative to provide a basket of reduced price medicines for non-communicable diseases (NCDs) to be sold through the public and private nonprofit sectors in programme countries.
Ashigbie, Paul G., Laing, Richard, Onyango, Monica A., Rockers, Peter C., Vian, Taryn, Wirtz, Veronika J.   +5 more
core   +1 more source

Access to Essential Cardiovascular Medicines in Pakistan: A National Survey on the Availability, Price, and Affordability, Using WHO/HAI Methodology

Frontiers in Pharmacology, 2021
Objective: This national survey was aimed at measuring the access to cardiovascular disease (CVD) medicines in terms of their availability, price, and affordability in Pakistan.
Amna Saeed, Amna Saeed, Amna Saeed, Amna Saeed, Faria Saeed, Hamid Saeed, Zikria Saleem, Caijun Yang, Caijun Yang, Caijun Yang, Jie Chang, Jie Chang, Jie Chang, Minghuan Jiang, Minghuan Jiang, Minghuan Jiang, Mingyue Zhao, Mingyue Zhao, Mingyue Zhao, Muhammad Saqlain, Wenjing Ji, Wenjing Ji, Wenjing Ji, Muhammad Majid Aziz, Muhammad Majid Aziz, Muhammad Majid Aziz, Krizzia Lambojon, Krizzia Lambojon, Krizzia Lambojon, Ali Hassan Gillani, Ali Hassan Gillani, Ali Hassan Gillani, Khezar Hayat, Khezar Hayat, Khezar Hayat, Khezar Hayat, Sabiha Gul, Yu Fang, Yu Fang, Yu Fang, Zaheer-Ud-Din Babar   +40 more
doaj   +1 more source

Access to Life-Saving Medicines and Intellectual Property Rights: An Ethical Assessment [PDF]

, 2011
© 2011 Cambridge University Press. Online edition of the journal is available at http://journals.cambridge.org/action/displayJournal?jid=CQHDying before one’s time has been a prominent theme in classic literature and poetry.
Aquinas, Aquinas, Aquinas, Brown, DORIS SCHROEDER, Finnis, Jentzsch, Leisinger, Locke, Mamunes, May, Nozick, Pang, PETER SINGER, Pogge, Pogge, Rawls, Rifkin, Schroeder, Selgelid, Shelley   +20 more
core   +2 more sources

What's in a Word? Falsified/Counterfeit/Fake Medicines - The Definitions Debate

Medicine Access @ Point of Care, 2017
There is a rising tide of criminal activity to manufacture and distribute falsified, counterfeit, or fake medicines. The exact size of this problem is unknown but estimates vary from US$75 billion to US$200 billion per year, and evidence clearly ...
Mike Isles
doaj   +1 more source

Pricing of drugs and donations: options for sustainable equity pricing. [PDF]

, 2001
Effective medicines exist to treat or alleviate many diseases which predominate in the developing world and cause high mortality and morbidity rates. Price should not be an obstacle preventing access to these medicines.
Ford, N, Herranz, E, Pérez-Casas, C
core   +2 more sources

Access to licenced vaccines for high-threat infectious diseases: a scoping review and interpretive analysis of Ebola virus disease

BMC Infectious Diseases
Background Outbreaks of high-threat zoonotic diseases like Ebola virus disease (EVD) occur more frequently, causing severe health and socioeconomic impacts.
Charlot Diepvens, Donovan Guttieres, Kim De Boeck, Nico Vandaele, Leonor Guariguata, Catherine Decouttere   +5 more
doaj   +1 more source

The International Right to Health: What Does It Mean in Legal Practice and How Can It Affect Priority Setting for Universal Health Coverage? [PDF]

, 2015
The international right to health is enshrined in national and international law. In a growing number of cases, individuals denied access to high-cost medicines and technologies under universal coverage systems have turned to the courts to challenge the ...
Chalkidou, Kalipso, Cubillos, Leonardo, Dittrich, Rebecca, Gostin, Lawrence O., Li, Ryan   +4 more
core   +2 more sources

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen, Calogero Virgone, Antje Redlich, Michael Abele, Ricardo Lopez‐Almaraz, Tal Ben‐Ami, Ewa Bien, Gianni Bisogno, Maja Mazic Cesen, Andrea Ferrari, Malgorzata A. Krawczyk, Yves Reguerre, Dominik T. Schneider, Ines B. Brecht, Charlotte Rigaud, Bilgehan Yalcin, Rainer Claus, Christian Vokuhl, Constantin Lapa, Jörg Fuchs, Segolene Hescot, Thomas Walter, Julien Hadoux, Daniel Orbach   +23 more
wiley   +1 more source

Perspectives on systematic capacity building in pharmaceutical regulation for regulators of medical products

Frontiers in Medicine
Having a robust, integrated regulatory system is important for ensuring the availability of safe and efficacious medical products of good quality and for protecting public health.
Luther Gwaza, Andrew Chemwolo, Mario Musonda, Rutendo Kuwana, Admire Dube   +4 more
doaj   +1 more source

The timelines for the price and reimbursement authorization in Italy 2018–2020

Frontiers in Medicine, 2022
ObjectiveThis investigation aimed to guarantee the principles of transparency in public administration; to inform citizens about the time to patient access to reimbursed medicines; to assess the duration of the P&R process for the first time in the ...
Valentina Gallo, Eva Alessi, Simona Montilla, Gianluca Altamura, Giuseppe Traversa, Francesco Trotta   +5 more
doaj   +1 more source